Blood Coagulation & Fibrinolysis

ISSN 0957-5235 · Lippincott Williams & Wilkins · United States · active 1990–2026

Metrics

Scimago quartile
Q3
Cites per paper (2y)
0.9
SJR
0.402
h-index
93

“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.

Is this the right journal for your paper?

The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.

Try the Journal Finder →

Indexing & access

ScopusWeb of SciencePubMed

Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.

Official journal site →

Scope

bloodcoagulationthrombosismechanismshematologyvenousthromboembolismdiagnosismanagementinternalmedicineplatelet

Frequently asked

Is Blood Coagulation & Fibrinolysis a predatory journal?

Our screening does not flag Blood Coagulation & Fibrinolysis. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.

Is Blood Coagulation & Fibrinolysis indexed in Scopus or Web of Science?

Per our venue index, Blood Coagulation & Fibrinolysis appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.

What is the impact factor of Blood Coagulation & Fibrinolysis?

Papers in Blood Coagulation & Fibrinolysis are cited about 0.9 times each within two years of publication, and Scimago places it in Q3, with an h-index of 93. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.

What Scimago quartile is Blood Coagulation & Fibrinolysis (Q1, Q2, Q3, or Q4)?

Scimago places Blood Coagulation & Fibrinolysis in Q3 for its subject category. Quartiles split the journals in a field into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Blood Coagulation & Fibrinolysis is cited about 0.9 times per paper over two years, with an h-index of 93. A journal is ranked per subject category, so one spanning several fields can sit in different quartiles depending on the category.

What is the Web of Science (JCR) quartile of Blood Coagulation & Fibrinolysis?

The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Blood Coagulation & Fibrinolysis. The open equivalent is its Scimago quartile, Q3, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.

Is Blood Coagulation & Fibrinolysis open access?

We hold no reliable open-access classification for Blood Coagulation & Fibrinolysis. Check the journal's own site for its access model and any article processing charge.

Ready to submit? Tools for your next paper

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Similar venues

Command palette

Jump anywhere, run any action.